Inventor · disambiguated record
Eric Van Quaquebeke
Also filed as: VAN QUAQUEBEKE ERIC
3 granted patents·8 pending applications·9 citations·filing 2003–2008
56Inventor score
Top patents by PatentIndex Score
11 records- 0176US7981875B22″ oxo-voruscharin and derivatives thereofUNIBIOSCREEN SA·Filed 2007·Granted Jul 19, 2011·8 cites·22 claims
- 0261US7741337B2Azonafide derivatives, methods for their production and pharmaceutical compositions therefromUNIBIOSCREEN SA·Filed 2006·Granted Jun 22, 2010·1 cites·4 claims
- 0350US2009221628A1Compositions and methods for treatment of prostate and breast cancerUNIBIOSCREEN SA·Filed 2008·Application pending·0 cites
- 0450US2009232907A1Compositions and methods for treatment of esophageal cancerUNIBIOSCREEN SA·Filed 2008·Application pending·0 cites
- 0550US2009186915A1Compositions and methods for treatment of glioblastoma, gliosarcoma, NSCLC, and head and neck cancerUNIBIOSCREEN SA·Filed 2008·Application pending·0 cites
- 0639US2010076005A1Isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activitiesUNIBIOSCREEN SA·Filed 2007·Application pending·0 cites
- 0738US2010068198A1Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseasesUNIBIOSCREEN SA·Filed 2006·Application pending·0 cites
- 0837US2007123473A1Glycosylated steroid derivatives with anti-migratory activityBRAEKMAN JEAN-CLAUDE·Filed 2004·Application pending·0 cites
- 0937US2007117836A1Napthalimide derivatives, methods for their production and pharmaceutical compositions therefromVAN QUAQUEBEKE ERIC·Filed 2006·Application pending·0 cites
- 1035US2009118321A15-Urea Substituted Naphthalimide Derivatives, Methods of Production and Pharmaceutical Compositions for Treating CancerUNIBIOSCREEN SA·Filed 2007·Application pending·0 cites
- 1129US7320971B22″ oxo-voruscharin and derivatives thereofUNIBIOSCREEN SA·Filed 2003·Granted Jan 22, 2008·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Eric Van Quaquebeke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →